Articles

Editors' (re)View: Intra-Cellular depression drug nears regulatory submission; Eli Lilly targets counterfeiters

June 21, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of June 17

Ensuring CAPA lives up to its name

June 20, 2024
How pharma can use CAPA as a tool to support continuous process improvement

Hurricane season is approaching, time for pharma manufacturers to buckle down 

June 18, 2024
Different disruptions call for different protocols and methods, and now is the time to prepare

Editors' (re)View: AdComm nod for Lilly Alzheimer's drug; SCOTUS mifepristone decision

June 14, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of June 10

Pharma manufacturing in the (virtual) clouds

June 13, 2024
Digital twins are a valuable tool for bringing the pharma industry into the future

Compliance fire drill: Mock FDA audits for cleaning validation

June 12, 2024
Pharma manufacturers should incorporate worst-case scenarios into assessment processes

Keeping pace with pharma packaging

June 11, 2024
Pharma manufacturers need modern printing, marking and coding solutions to ensure compliance and stay ahead of trends

Harnessing the power of bispecific antibodies

June 10, 2024
With increased pharma partnerships, FDA approvals and positive market trends, bispecific antibodies are here to stay

Editors' (re)View: Warp speed: The next generation; FDA Adcomm votes against MDMA for PTSD 

June 7, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of June 3

Warp speed: The next generation in pharma

June 7, 2024
Six pharma companies have revealed that they were chosen to participate in the FDA's rare disease pilot program

Removing reshoring's gold-colored glasses

June 6, 2024
What will it take to make domestic drug production more than a glint in the pan?

Building the next generation of future-ready pharma labs

June 6, 2024
To achieve lab transformation, leaders must confront challenges in data, technology, people and processes

Pushing the boundaries of health with pharma tech advancements

June 4, 2024
From drug containment solutions to modern manufacturing technologies, the latest advancements are setting new standards for what’s possible in health care

Virginia is for pharma lovers

June 3, 2024
Richmond has rebounded from its tobacco breakup and is courting a serious relationship with advanced manufacturing technology

Editors' (re)View: Pandemic disagreements; GDUFA research recap

May 31, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of May 27

Shoring up pharma supply chains

May 30, 2024
Aging populations are straining pharma production — here’s what the industry should do

U.S. legislation and directives for domestic drug manufacturing

May 29, 2024
The U.S. movement to repatriate generic drugs, APIs and ingredients has triggered a rush of legislation

Mining the reshoring rush: Targeting government spending

May 29, 2024
In part one of our series, we discuss efforts to establish a comprehensive reshoring list

Mining the reshoring rush: Sustaining efforts once infrastructure investments dry up

May 29, 2024
In part two of our series, we explore what it will take for domestic companies to be self-sustaining and the role of advanced technologies

Mining pharma's reshoring rush

May 29, 2024
It’s time for the U.S. to sift through domestic drug manufacturing efforts

Editors' (re)View: More lawsuits for J&J; Abortion pills as controlled substances

May 24, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of May 20

The key to ending drug shortages: data transparency

May 20, 2024
By connecting quality, regulatory and manufacturing data, companies can bring agility across the supply chain

Editors' (re)View: Hot flash treatment space heats up; Alzheimer's resilience

May 17, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of May 13

The untapped potential of drug capsules

May 14, 2024
What groundbreaking innovations lie ahead for capsules and how will these developments redefine their role in drug delivery?

Converting viral vector facilities to mRNA  

May 13, 2024
With the right considerations, pharma can pivot its plants to meet market needs

Editors' (re)View: AML trial challenges; FTC digs into Novo-Catalent deal

May 10, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of May 5

Mitigating bioaerosol risks in pharma plants

May 6, 2024
Amid limited guidance from regulators, facility designers can deliver significant safety advantages by tackling risks at the source

Editors' (re)View: The fate of Emergent's plants; ADC win for Pfizer, Genmab

May 3, 2024
Pharma Manufacturing editors Karen Langhauser and Andrea Corona comment on the notable happenings in the pharma industry from the week of April 29